SVMC: "The cost is also significantly lower. Some disinfection technology can cost more than $50,000 per device."
“Cost is an important concern in health care” Salkin explained. “We are happy we could find a low-cost solution. By using it, we can help ensure that our patients are safer, and that’s what’s really important.”
-----
Sanosil: $5,000 per unit
Medizone: CD$125,000 per system
-----
Sanosil: 200 independent tests
Medizone: 0 independent tests
-----
Sanosil: EPA approval - YES
Medizone: EPA approval - NO
-----
Sanosil: Statistically significant HAI reduction data - YES
Medizone: Statistically significant HAI reduction data - NO! (NOT SHOWN A 1% REDUCTION LET ALONE 100%) ["HAI reduction rates and pathogen-specific log reductions are two different measurements and should not be confused as being the same" Shannon]
-----
Sanosil: Completed hospital studies show a significant reduction in the number of clostridium difficile infections (During a recent study of the HDS system at Pennsylvania Hospital, a 496-bed urban teaching hospital in Philadelphia, PA, infection control experts cut the rate of C. diff infections by 66% after deploying the HDS system in patient rooms, operating rooms and treatment areas.)
Medizone: HAVE NOT COMMENCED even one of the "THREE HOSPITAL TRIALS PLANNED FOR 2012" ('Insider Hospital' - Belleville General's reported C. difficile infection rate higher than the provincial average IN EVERY MONTH OF 2013 apart from February)
10Q, June 30, 2012: "In recent developments based on potential customer surveys for both the veterinary and hospital sectors, the service model appears to be a preferred choice."
TO DATE, NOT ONE(1) SALE TO A HOSPITAL NOR ONE(1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED (The manufacture of the first production machine was announced back in April 2012)
Market Data 
Markets 
AI
